Tag: #Global Trends

U.S. pharmaceutical titan Pfizer is officially reviewing the timeline and physical scope of its planned investments within Germany. The corporate... Read more

Danish pharmaceutical innovator Novo Nordisk headed to the High Court in Pretoria, South Africa, to secure an injunction aimed at... Read more

French pharmaceutical giant Sanofi has officially announced the discontinuation of a late-stage clinical trial evaluating its experimental anti-inflammatory molecule, riliprubart.... Read more

The U.S. Food and Drug Administration (FDA) has officially approved an extended every-8-week (Q8W) maintenance dosing regimen for Eli Lilly... Read more

Biopharmaceutical leaders Genentech and Novartis have co-sponsored a novel four-part digital microdrama series tracking the daily lives of young adults... Read more

Teva Pharmaceuticals plans to eliminate 250 jobs within its contract development and manufacturing organization (CDMO) unit over the next two... Read more

Swiss pharmaceutical and diagnostics giant Roche has officially confirmed to Reuters that it is maintaining its planned capital investments in... Read more

South Korean technology giant Samsung Electronics has officially announced a $175 million capital deployment into Element Biosciences, a privately held,... Read more

Gilead Sciences and its partner Merck & Co. have officially announced the discontinuation of their Phase 3 Evoke-03 clinical trial... Read more